ArticleJournal of pathology informatics2026
Weakly supervised deep learning distinguishes alcohol-associated from metabolic dysfunction-associated steatohepatitis on H&E whole-slide images.
Article in Journal of pathology informatics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Distinguishing alcohol-associated steatohepatitis (ASH) from metabolic dysfunction-associated steatohepatitis (MASH) is challenging given the absence of pathognomonic differentiators. We developed and evaluated a weakly supervised deep learning model, as a single-institution proof-of-concept study, to test whether routine hematoxylin and eosin (H&E) whole-slide images (WSIs) of liver biopsies contain sufficient morphological information to predict steatohepatitis etiology at the slide level. A retrospective cohort of 1147 WSIs was assembled (train set: 1007, holdout test set: 140). Models were trained using 5-fold patient-level cross-validation at ×20 and ×40 magnification. Model interpretability was assessed through attention-based clustering with blinded pathologist review of high-attention patches. The ×20 model achieved a mean area under the receiver operating characteristic of 0.86 ± 0.01 on the test set, with balanced accuracy of 0.80. The ×40 model performed comparably. Specificity was high (0.93 at ×20), with an ASH sensitivity of 0.67 at ×20. Fibrosis-stratified showed preserved performance at advanced fibrosis (stage ≥3) with balanced accuracy of 82.5% and ASH sensitivity of 77.4%. Attention-based clustering localized ASH-enriched regions to active injury patterns including Mallory-Denk bodies, neutrophilic inflammation, cholestatic change, and pericellular fibrosis, whereas MASH-enriched regions showed steatosis with lower inflammatory activity. Weakly supervised deep learning applied to routine liver H&E WSIs can discriminate ASH from MASH with performance preserved at advanced fibrosis. The comparable performance of ×20 and ×40 magnification, and the alignment of model attention with established histological features, support the use of routine morphology as a decision-support input in cases with incomplete or conflicting clinical histories, particularly when the etiological distinction has the greatest implications for management.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.